The New England Revolution have signed homegrown midfielder Jack Panayotou through the 2026 MLS season with an option for 2027, the club announced Tuesday. The 18-year-old US youth international turns ...

Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-0.87 EPS, expectations were $-0.84. Operator: Good day and thank you for standing by. Welcome to the Revolution Medicines ...

The New England Revolution landed a speedy midfielder from the Big 10 and two center backs from the ACC in Wednesday night’s 2023 MLS SuperDraft. The Revolution began the draft with the 10th pick in ...

Good day, and thank you for standing by. Welcome to the Revolution Medicines Q4 Year-End 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' ...